Condition: Focal Epilepsy · Sponsor: Biohaven Therapeutics Ltd.
The purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Onyx Clinical Trials | Peoria, Arizona, United States | — |
| Xenoscience, Inc. | Phoenix, Arizona, United States | — |
| University of Arizona / Banner University Medical Center Phoenix | Phoenix, Arizona, United States | — |
| ARENSIA Exploratory Medicine | Phoenix, Arizona, United States | — |
| Clinical Trials, Inc. | Little Rock, Arkansas, United States | — |
| Tri Valley Neurology Medical Associates, Inc. | Mission Hills, California, United States | — |
| Profound Research LLC | Poway, California, United States | — |
| UConn Health | Farmington, Connecticut, United States | — |
| Nova Clinical Research, LLC | Bradenton, Florida, United States | — |
| Las Mercedes Medical Research | Hialeah, Florida, United States | — |
| Coral Clinic Research | Homestead, Florida, United States | — |
| Y&L Advance Health Care, Inc d/b/a Elite Clinical Research | Miami, Florida, United States | — |
+ 140 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.